Carretta, C., S. Rontauroli, M. Bertesi, S. Parenti, M. Maccaferri, D. Benati, M. Malerba, A. Neroni, E. Papa, R. Norfo, M. Mirabile, L. Tavernari, C. Tombari, P. Guglielmelli, A. Recchia, L. Potenza, E. Tagliafico, M. Luppi, A. Vannucchi, and R. Manfredini. 2026. “CO58 | Single-Cell Multi-Omics Unravels Molecular and Cellular Programs Underlying Ruxolitinib Response in Myelofibrosis: C. Carretta1|2, S. Rontauroli1|2, M. Bertesi1|3, S. Parenti1|2, M. Maccaferri4, D. Benati1|3, M. Malerba1|3, A. Neroni1|3, E. Papa1|3, R. Norfo1|2, M. Mirabile1|3, L. Tavernari1|2, C. Tombari1|2, P. Guglielmelli5|6, A. Recchia1|3, L. Potenza4|7, E. Tagliafico7|8, M. Luppi4|7, A. Vannucchi5|6, R. Manfredini1|2 | 1Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia; 2Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia; 3Department of Life Sciences, University of Modena and Reggio Emilia; 4Department Oncology and Hematology, Hematology Unit, Modena University Hospital; 5CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence; 6Department of Experimental and Clinical Medicine, University of Florence; 7Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia; 8Department of Laboratory Medicine, Diagnostic Hematology and Clinical Genomics Unit, Modena University Hospital”. Haematologica 111 (s1). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s1.61.